to be exact, it is a publication of the data presented at AACR, which can be seen in kza’s June 22 release.
- Forums
- ASX - By Stock
- KZA
- Interim Results of Phase 2 GBM Trial Released
Interim Results of Phase 2 GBM Trial Released, page-4
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online